Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

Olivia Oxlade, Kevin Schwartzman, Dick Menzies

PubMed · 2007 · 120 citations · 57 references

Abstract

Screening for LTBI, with TST or QFT, is cost-effective only if the risk of disease is high. The most cost-effective use of QFT is to test TST-positive persons.

References

57